Rockefeller Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-825
Closed -$18K 498
2014
Q3
$18K Hold
825
﹤0.01% 434
2014
Q2
$17K Hold
825
﹤0.01% 485
2014
Q1
$18K Hold
825
﹤0.01% 461
2013
Q4
$17K Sell
825
-1
-0.1% -$19 ﹤0.01% 445
2013
Q3
$16K Buy
826
+15
+2% +$287 ﹤0.01% 454
2013
Q2
$14K Buy
+811
New +$14.6K ﹤0.01% 455

Other funds holding HQL

Rockefeller Financial Services's HQL Position: Q4 2014 in Review

Rockefeller Financial Services sold out of abrdn Life Sciences Investors (HQL) in Q4 2014, closing a stake of 825 shares — an estimated $18K sold.

Rockefeller Financial Services first reported a position in HQL in Q2 2013 and held it in 6 quarters. The position peaked at $18K in Q3 2014. 45 funds tracked by Wall St. Rank hold HQL as of Q4 2014.

  • Rockefeller Financial Services reported no remaining abrdn Life Sciences Investors position as of Q4 2014 after selling out during the quarter.
  • Rockefeller Financial Services sold 825 abrdn Life Sciences Investors shares in Q4 2014, an estimated $18K.
  • Rockefeller Financial Services first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 6 quarters.
  • Rockefeller Financial Services's abrdn Life Sciences Investors position peaked at $18K in Q3 2014.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2014.

Based on Rockefeller Financial Services's 13F filing for Q4 2014, filed 28 Jan 2015.